Skip to content

Clinical trials

Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 3 Country / region: Austria Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20051
20071
20131
20142
20151
20172
20181
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Unknown status3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Novartis Pharmaceuticals2
St. Anna Kinderkrebsforschung2
AbbVie1
Bristol-Myers Squibb1
Charite University, Berlin, Germany1
Children's Oncology Group1
Gilead Sciences1
Martin Schrappe1
Princess Maxima Center for Pediatric Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma15
Burkitt Lymphoma2
Leukemia2
Leukemia, Biphenotypic, Acute2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Non-Hodgkin2
Neoplasms2
Recurrence2
Immunoproliferative Disorders1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.